Advances in histone deacetylase inhibitors in targeting glioblastoma stem cells R. Gajendra ReddyUnis Ahmad BhatArvind Kumar Review Article 07 July 2020 Pages: 165 - 179
Population pharmacokinetics–pharmacodynamics of sunitinib in pediatric patients with solid tumors Erjian WangSteven G. DuBoisReza Khosravan Original Article Open access 04 July 2020 Pages: 181 - 192
A randomized, double-blind, parallel-group, single‑dose, pharmacokinetic bioequivalence study of INTP24 and bevacizumab in healthy adult men Inderjeet SinghRonak PatelVinu Jose Original Article 05 July 2020 Pages: 193 - 202
Chemotherapy-induced neutropenia as a prognostic factor in patients with pancreatic cancer treated with gemcitabine plus nab-paclitaxel: a retrospective cohort study Motoyasu KanHiroshi ImaokaMasafumi Ikeda Original Article 06 July 2020 Pages: 203 - 210
Phase I safety and pharmacokinetic study of YM155, a potent selective survivin inhibitor, in combination with erlotinib in patients with EGFR TKI refractory advanced non-small cell lung cancer Toshio ShimizuKazuto NishioKazuhiko Nakagawa Original Article 08 July 2020 Pages: 211 - 219
Inhibition of autophagy by chloroquine enhances the antitumor activity of gemcitabine for gallbladder cancer Fang-Tao WangHui WangYue-Zu Fan Original Article 11 July 2020 Pages: 221 - 232
Association of dry skin with intercellular lipid composition of stratum corneum after erlotinib administration Tomonobu UchinoHiyori FujinoYoshiyuki Kagawa Original Article 15 July 2020 Pages: 233 - 243
Cytotoxic and biomechanical effects of clinical dosing schemes of paclitaxel on neurons and cancer cells Chou-Ching K. LinChih-Hsuan YangMing-Shaung Ju Original Article 19 July 2020 Pages: 245 - 255
Chemosensitization by 4-hydroxyphenyl retinamide-induced NF-κB inhibition in acute myeloid leukemia cells Hui ZhangHaoyu XuFenggui Wei Original Article 21 July 2020 Pages: 257 - 266
A phase Ι study to evaluate the application of photocyanine using pharmacokinetic and pharmacodynamic analysis in patients with malignancy Su LiBingtian BiGuoliang Xu Original Article 24 July 2020 Pages: 267 - 276
Phase Ib study of FOLFOXIRI plus ramucirumab as first-line treatment for patients with metastatic colorectal cancer Yosuke KitoHironaga SatakeKentaro Yamazaki Original Article 24 July 2020 Pages: 277 - 284
A phase I/II study of S-1 and irinotecan (IRIS) combined with cetuximab in patients with RAS wild-type metastatic colorectal cancer (KSCC1401) Hironori SamuraEiji OkiMasaki Mori Original Article 30 July 2020 Pages: 285 - 294
HOTAIR promotes paclitaxel resistance by regulating CHEK1 in ovarian cancer Jiahong JiangShaohai WangChun Yang Original Article 02 August 2020 Pages: 295 - 305
Excretion balance and pharmacokinetics following a single oral dose of [14C]-fedratinib in healthy subjects Ken OgasawaraChristine XuGopal Krishna Original Article 03 August 2020 Pages: 307 - 314
ABCB1 and ABCC2 genetic polymorphism as risk factors for neutropenia in esophageal cancer patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapy Hisanaga NomuraDaiki TsujiToshikatsu Kawasaki Original Article 03 August 2020 Pages: 315 - 324